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healthy and osteoarthritic chondrocytes
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Abstract
Introduction: Hypoxia is considered to be a positive influence on the healthy chondrocyte phenotype and
cartilage matrix formation. However, hypoxia-inducible factors (HIFs) have been implicated in the pathogenesis of
osteoarthritis (OA). Thus, we assessed whether healthy and OA chondrocytes have distinct responses to oxygen,
particularly with regard to hypertrophy and degradation during redifferentiation.
Methods: Monolayer-expanded healthy and OA chondrocytes were redifferentiated for 14 days in pellet cultures
under standard (20% oxygen) or hypoxic (2% oxygen) conditions. Cartilage matrix gene expression, matrix quality
and quantity, degradative enzyme expression and HIF expression were measured.
Results: In hypoxia, both healthy and OA chondrocytes had higher human collagen type II, a1 gene (COL2A1),
and aggrecan (ACAN) expression and sulfated glycosaminoglycan (sGAG) accumulation, concomitant with lower
human collagen type X, a1 gene (COL10A1), and human collagen type I, a1 gene (COL1A1), expression and
collagen I extracellular accumulation. OA chondrocytes had significantly lower sGAGs/DNA than healthy
chondrocytes, but only in high oxygen conditions. Hypoxia also caused significantly greater sGAG retention and
hyaluronic acid synthase 2 (HAS2) expression by OA chondrocytes. Both healthy and OA chondrocytes had
significantly lower expression of matrix metalloproteinases (MMPs) MMP1, MMP2, MMP3 and MMP13 in hypoxia
and less active MMP2 enzyme, consistent with lower MMP14 expression. However, aggrecanase (ADAMTS4 and
ADAMTS5) expression was significantly lowered by hypoxia only in healthy cells, and COL10A1 and MMP13
remained significantly higher in OA chondrocytes than in healthy chondrocytes in hypoxic conditions. HIF-1a
and HIF-2a had similar expression profiles in healthy and OA cells, increasing to maximal levels early in hypoxia
and decreasing over time.
Conclusions: Hypoxic culture of human chondrocytes has long been acknowledged to result in increased matrix
accumulation, but still little is known of its effects on catabolism. We show herein that the increased expression of
matrix proteins, combined with decreased expression of numerous degradative enzymes by hypoxia, minimizes but
does not abolish differences between redifferentiated healthy and OA chondrocytes. Hypoxia-induced HIF
expression is associated with hypertrophic marker and degradative enzyme downregulation and increased
measures of redifferentiation in both healthy and OA chondrocytes. Therefore, though HIFs may be involved in the
pathogenesis of OA, conditions that promote HIF expression in vitro promote matrix accumulation and decrease
degradation and hypertrophy, even in cells from OA joints.
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Introduction
The proper application of cellular therapies for articular
cartilage repair is hindered by a lack of clarity with regard
to the mechanisms that underlie the development and
maintenance of the permanent chondrocyte phenotype as
opposed to the transient endochondral phenotype. During
endochondral ossification in development, transient chon-
drocytes of the anlagen undergo hypertrophy prior to
apoptosis and replacement by bone. It is argued that
hypertrophy is also a feature of osteoarthritis (OA)
because the permanent chondrocytes of articular cartilage
can express markers of hypertrophic endochondral chon-
drocytes, such as collagen X (COL10A1) and matrix metal-
loproteinase 13 (MMP13) during degeneration. The use of
chondrocytes for cartilage repair requires in vitro expan-
sion, a process that leads to dedifferentiation whereby
the chondrocytes decrease expression of cartilage matrix
genes such as aggrecan (ACAN) and collagen II
(COL2A1), with collagen I (COL1A1) becoming the predo-
minant collagen type [1]. Although it has long been estab-
lished that these chondrocytes can be redifferentiated in
three-dimensional culture [2], this may not be completely
successful, because hypertrophy-related markers can also
be upregulated, even in chondrocytes from nondiseased
joints [3,4]. Therefore, achieving a better understanding of
the factors regulating hypertrophy has important implica-
tions both for tissue engineering and for treatment of OA.
Although it is known that oxygen levels and the Per-
Arnt-Sim (PAS) family of transcription factors known as
hypoxia-inducible factors (HIFs), particularly HIF-1a
and HIF-2a, play an active role in chondrocyte biology,
their precise contributions to both cartilage maintenance
and the progression of disease remain unclear [5-7].
These a-subunits are subject to degradation in the pre-
sence of sufficient oxygen, but in hypoxic environments
such as the avascular joint, their stabilization allows het-
erodimerization and transactivation of hypoxia-respon-
sive target genes. In vitro hypoxic culture of healthy
human chondrocytes or cartilage explants causes an
increase in HIF expression and promotes chondrogenic
matrix genes [8-10] while suppressing MMP-1 and
MMP-13 expression and activity [10,11] and decreasing
ADAMTS5 mRNA expression and aggrecanase-mediated
degeneration [10]. However, recent data suggest that
HIF-2a can promote expression of genes involved in
cartilage degeneration and hypertrophy [12,13]. The
potential relevance of oxygen-dependent signaling to
OA has been acknowledged for some time. In the past
decade, multiple groups have reported elevated HIF-1a
expression in degenerated cartilage [14-16]. However,
two groups have independently identified numerous
hypertrophic and OA-associated genes as targets of
HIF-2a regulation, including COL10A1 and matrix
metalloproteinases MMP1, MMP3, MMP9 and MMP13,
using reporter gene assays [12,13]. These studies pro-
voked considerable speculation about the importance of
HIF-2a in hypertrophy and OA [17], but other studies
have raised questions about its role in these processes
[5,7]. For example, Araldi et al. found that conditional
knockout of Epas1 (the HIF-2a gene) had minimal
effects on Col10a1 expression [5]. As noted in a com-
mentary on the initial HIF-2a/hypertrophy reports, the
data are from in vitro overexpression studies conducted
in 20% oxygen [6]. Because oxygen-dependent posttran-
slational regulation of HIFs is thought to be the primary
means of control, such culture conditions may have
influenced the observed downstream effects.
In our present study, we investigated the effects of
oxygen on three-dimensional redifferentiation in both
healthy and OA chondrocytes. The proteomes of dediffer-
entiated OA and healthy chondrocytes were reported to
be differentially modulated by changes in oxygen tension
using cells in monolayer culture [18] and more recently
were shown to differentially respond to hypoxia when cul-
tured with interleukin 1b (IL-1b) [19]; however, we are
aware of no such comparison during three-dimensional
redifferentiation published to date. Three-dimensional cul-
ture of chondrocytes in defined medium promotes matrix
accumulation and redifferentiation [20]. Although this is
considered preferable for chondrocytes that are to be
implanted, it can also increase expression of hypertrophic
genes. For example, Dehne et al. found that runt-related
transcription factor 2 (RUNX2) and COL10A1 were both
increased during redifferentiation, regardless of whether
the cells were of nondiseased or osteoarthritic origin [3].
An increase in COL10A1 upon three-dimensional culture
was also reported for chondrocytes from both total joint
replacement knees and autologous chondrocyte implanta-
tion surplus cartilage [4]. Because three-dimensional cul-
ture can promote redifferentiation while also increasing
markers of hypertrophy, this system allows a comparative
analysis of the hypertrophic and degradative response that
could be missed in monolayer culture. We hypothesized
that this response might be differentially regulated by
hypoxia in OA and healthy chondrocytes concomitant
with different HIF expression patterns. To investigate this
possibility, we evaluated healthy and OA chondrocytes’
hypertrophic and degradative responses to hypoxia (2%
oxygen), as well as the nature and quantity of matrix pro-
duction and expression of HIFs.
Materials and methods
Isolation and expansion of human chondrocytes
Healthy chondrocytes were harvested from normal cada-
ver femoral condyles and OA chondrocytes from tissue
taken during total joint replacement surgery (n = 5
each; for representative images, see Additional file 1).
Human tissue was obtained as discard tissue without
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patient identifiers. The Oregon Health & Science Uni-
versity Institutional Review Board approved the study as
being exempt from the requirement for consent. Carti-
lage was scraped from the condyles and finely minced
before enzymatic digestion. Cartilage digestion was
initiated with 1% protease (wt/vol) from Streptomyces
griseus in low-glucose Dulbecco’s modified Eagle’s med-
ium (DMEM; Life Technologies, Grand Island, NY,
USA) supplemented with 1% penicillin-streptomycin
(P/S). After 1 h at 37°C, protease was removed and
replaced with 1,300 U/ml collagenase II (Worthington
Biochemical, Lakewood, NJ, USA) in DMEM + P/S for
3 h at 37°C. The cell suspension was passed through a
40-μm cell strainer and centrifuged at 500 × g for
5 min, then the cells were resuspended in low-glucose
DMEM supplemented with 10% fetal bovine serum and
1% P/S. Chondrocytes were plated at 7,000/cm2 and
expanded in monolayer culture in a standard tissue cul-
ture incubator with atmospheric oxygen and 5% CO2.
The storage conditions for osteochondral allografts
may affect chondrocyte viability and metabolic activity,
although the time at which these effects become evident
depends on the storage solution, and in some medium
solutions no change is observed even after 2 wk [21]. We
obtained OA specimens just hours after total joint repla-
cement, and healthy cartilage was collected from dis-
carded osteochondral allografts of proprietary storage
conditions. For the chondrocytes used here, however, we
found no significant difference in either the number of
viable cells obtained per gram of tissue digested (5.1 ×
106 ± 3.3 × 106 versus 6.2 × 106 ± 3.1 × 106, for healthy
and OA cells, respectively) or in the doubling time from
initial plating to first passage (6.9 ± 2.1 versus 6.4 ± 1.5
for healthy and OA cells, respectively).
Pellet culture redifferentiation of chondrocytes
Chondrocytes were redifferentiated between the first and
third passages with serum-free chondrogenic induction
medium consisting of high-glucose DMEM (Life Technol-
ogies) containing 10 ng/ml transforming growth factor b1
(Peprotech, Rocky Hill, NJ, USA), 10-7 M dexamethasone,
37.5 μg/ml ascorbic acid 2-phosphate, 1 mM sodium pyru-
vate, 40 μg/ml L-proline, 1 × ITS+ Universal Culture Sup-
plement Premix (BD Biosciences, San Jose, CA, USA) and
1% P/S. Pellet cultures were formed by centrifuging 1 ×
105 cells at 500 × g in 250 μl of medium in Nunc polypro-
pylene V-bottom 96-well plates (Thermo Fisher Scientific,
Waltham, MA, USA) and maintained in a hypoxic cham-
ber (BioSpherix, Lacona, NY, USA) set at 2% oxygen, 5%
CO2 or a standard tissue culture incubator with 5% CO2.
Although CO2 displacement actually lowers the oxygen
level, hereafter we refer to the standard condition as 20%
oxygen according to convention. Medium was changed
every 2 or 3 days, with that of the hypoxic cultures being
done at 2% oxygen.
Biochemical assays
All biochemical assays were conducted on at least tripli-
cate pellets. Pellets were rinsed with phosphate-buffered
saline (PBS) and digested overnight at 60°C in 4 U/ml
papain (Sigma-Aldrich, St Louis, MO, USA) in PBS con-
taining 6 mM Na2-ethylenediaminetetraacetic acid and
6 mM L-cysteine (papain buffer, pH 6.0). For samples to
be assayed for hydroxyproline, iodoacetic acid was
added to a final concentration of 10 mM after papain
digestion.
DNA content of all papain-digested pellets was quanti-
fied using 2 μg/ml Hoechst dye with calf thymus DNA
diluted in papain buffer used to prepare standard curves.
Briefly, 50 μl of samples, standards and blanks were added
to black 96-well plates with 200 μl of Hoechst dye before
fluorescence emission was measured with a multiwell
plate reader (excitation 355 nm, emission 455 nm).
The sulfated glycosaminoglycan (sGAG) content of
pellets and culture medium was quantified using 1,9-
dimethymethylene blue (DMMB) dye. Supernatant col-
lected at each medium change was used to quantify the
total amount of sGAGs produced and lost into the med-
ium. Shark chondroitin sulfate diluted in either DMEM
or papain buffer was used to prepare standard curves.
For microplate assays, 50 μl of samples, standards and
blanks were added to clear 96-well plates with 200 μl of
DMMB dye (18 μg/ml in 0.5% ethanol, 0.2% formic
acid, 30 mM sodium formate; pH 3.0) before absorbance
was measured (575 nm).
Hydroxyproline content of pellets was quantified using
an adaptation of the chloramine-T hydrate oxidation/p-
dimethylaminobenzaldehyde development method with
solid-phase hydrolysis on Dowex 50WX8-400 ion
exchange resin (Thermo Fisher Scientific) [22]. Trans-4-
hydroxy-L-proline in papain buffer was used to generate
a standard curve. Absorbance of samples was measured
at 560 nm in a multiwell plate reader.
RNA isolation and real-time quantitative polymerase
chain reaction
The RNeasy Mini Kit (QIAGEN, Germantown, MD,
USA) was used to collect total RNA from four to six
pellets of each condition. Pooled pellets were snap-fro-
zen in liquid nitrogen and crushed, then immediately
lysed with Buffer RLT lysis buffer (QIAGEN) containing
40 mM dithiothreitol (DTT). RNA isolation then pro-
ceeded as per the manufacturer’s instructions.
RNA samples (250 ng) were reverse-transcribed using
qScript cDNA SuperMix (Quanta BioSciences, Gaithers-
burg, MD, USA) as per the manufacturer’s instructions.
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Quantitative polymerase chain reaction (qPCR) analysis was
performed using a MyiQ iCycler thermal cycler (Bio-Rad
Laboratories, Hercules, CA, USA) with PerfeCTa qPCR
FastMix (Quanta BioSciences) and TaqMan assays (Life
Technologies) for ACAN (Hs00153936_m1), COL2A1
(Hs00264051_m1), COL1A1 (Hs00164004_m1), COL10A1
(Hs00166657_m1), MMP1 (Hs00899658_m1), MMP2
(Hs00234422_m1), MMP3 (Hs00968305_m1), MMP9
(Hs00234579_m1), MMP13 (Hs00233992_m1), MMP14
(Hs00237119_m1), TIMP2 (Hs00234278_m1), ADAMTS4
(Hs00192708_m1), ADAMTS5 (Hs00199841_m1), HAS2
(Hs00193435_m1), HIF1A (Hs00153153_m1) and EPAS1
(Hs01026149_m1). The cycling parameters were 45°C for
2 min, 95°C for 1 min, then 95°C for 5 s and 60°C for 30 s
for a total of 40 cycles. Results were analyzed using the
2-ΔCt method relative to the housekeeping gene 18S
(Hs99999901_s1).
Gelatin zymography
Gelatin zymography was performed on 10% SDS-PAGE
gels containing 10 mg/ml gelatin. Gelatin was dissolved in
1.5 M Tris, pH 8.8, and displaced a corresponding volume
of 1.5 M Tris during gel preparation. Medium samples
from days 9 to 14 of pellet culture were pooled for each
oxygen condition. Pooled samples were prepared in Lam-
meli sample buffer without reducing agents or boiling, and
20 μl of this solution was used for zymography. Samples
were run alongside PageRuler Plus marker (Thermo Fisher
Scientific), then gels were incubated in renaturing buffer
(2.7% Triton X-100) two times for 30 min each before
equilibrating in developing buffer (50 mM Tris base,
5 mM CaCl2, 40 mM HCl, 200 mM NaCl, 0.02% (wt/vol)
Brij-35) for 30 min at room temperature. The developing
buffer was then changed, and the gels were incubated at
37°C for 24 h. Developed zymograms were stained with
Coomassie Blue (0.1% Coomassie R-250, 10% acetic acid,
40% methanol) for 45 min, then destained in a solution of
10% acetic acid and 20% methanol until bands were
resolved.
Immunohistochemical analysis
Pellets were fixed in 10% neutral buffered formalin,
embedded in paraffin and sectioned onto slides. Sections
were deparaffinized and treated with 1 mg/ml protease
in PBS for 30 min at room temperature. For collagen I
and collagen II double-staining, protease treatment was
followed by 1 mg/ml hyaluronidase in PBS for 30 min at
37°C. Slides blocked with 5% bovine serum albumin
(BSA) were probed overnight at 4°C with primary anti-
bodies to collagen I (rabbit polyclonal antibody, 1:200;
kind gift from A Hollander, University of Bristol, UK),
collagen II (II-II6B3 mouse monoclonal antibody, 1:200;
Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA, USA), and collagen X (mouse poly-
clonal antibody, 1:300; kind gift from GJ Gibson, Henry
Ford Hospital, Detroit, MI, USA) diluted in 1% BSA.
Secondary antibodies (Oregon Green-conjugated anti-
rabbit (1:250) and Alexa Fluor 596-conjugated anti-
mouse (1:500) for double-staining; fluorescein isothiocya-
nate-conjugated anti-mouse diluted 1:500 for collagen X)
were added in 1% BSA for 45 min at room temperature.
Slides were mounted with ProLong Gold antifade reagent
containing 4′,6-diamidino-2-phenylindole (Life Technol-
ogies) and imaged using an Olympus BX51 microscope
(Olympus America, Melville, NY, USA).
Western blot analysis
Whole-cell lysates were obtained by pooling 20 pellets
from each condition at days 2, 7 and 14. Pellets were
rinsed with PBS, snap-frozen in liquid nitrogen and
crushed. The powdered sample was immediately resus-
pended in an enhanced radioimmunoprecipitation assay
buffer with 1% SDS and 100 mM DTT [23]. Hypoxic cul-
tures were maintained in low oxygen until directly before
freezing.
Lysates were prepared in Laemmli sample buffer with
100 mM DTT and boiled for 3 min. Samples were run on
12% SDS-PAGE gels for histone H3 and on 6% SDS-
PAGE gels for HIF blots using PageRuler Plus Prestained
Protein Ladder (Molecular Weight Marker) (Thermo
Fisher Scientific). Gels were transferred to polyvinylidene
difluoride and blocked for 1 h with 2% milk-PBST (1 ×
PBS, 0.1% Tween 20) at room temperature. Primary anti-
body incubations were done in blocking solution overnight
at 4°C. All washes were done three times for 10 min each
in PBST.
The quantity of nuclear protein loaded between sam-
ples was normalized to histone H3. The relative signal
of bands from a blot with equal volumes of lysates
loaded were determined using an Odyssey imaging sys-
tem (LI-COR Biosciences, Lincoln, NE, USA), and lysate
volumes were adjusted accordingly for HIF protein
blots. Anti-histone H3 primary antibody (ab24834;
Abcam, Cambridge, MA, USA) was used at a 1:500 dilu-
tion, and IRDye 800CW secondary antibody (catalog no.
926-32210; LI-COR Biosciences) was used at a 1:400
dilution. HIF blots were probed with anti-HIF-1a (1:250
dilution, catalog no. 610958; BD Biosciences) and anti-
HIF2a antibodies (1:500 dilution, sc-46691; Santa Cruz
Biotechnology, Santa Cruz, CA, USA). To visualize
blots, horseradish peroxidase-conjugated secondary anti-
body (1:2,500 dilution, catalog no. W4021; Promega,
Madison, WI, USA) and Western Lightning Plus-ECL
(PerkinElmer, Waltham, MA, USA) were used with a
Kodak RP X-OMAT Developer (Eastman Kodak Health
Imaging, Rochester, NY, USA).
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Statistical analysis
SPSS version 19.0 software (SPSS, Chicago, IL, USA)
was used to assess statistical significance, which was
defined as P < 0.05. Normality was evaluated using the
Shapiro-Wilk test. Two-tailed independent t-tests or
paired t-tests were used for normally distributed data,
and Mann-Whitney U or Wilcoxon tests were used for
nonparametric data. The unpaired tests were used to
compare means for healthy chondrocytes with those of
OA chondrocytes at a given oxygen level, and paired
tests were used to compare means between oxygen
levels within a given disease condition. The correlation
coefficient, Pearson’s r, for the ratios of mRNA expres-
sion of hyaluronic acid synthase 2 (HAS2) and sGAG
retention at 2% oxygen over 20% oxygen was deter-
mined using bivariate analysis.
Results
Oxygen-dependent expression of cartilage matrix genes
When the expression levels of major matrix genes were
compared, healthy and OA chondrocytes had similar
responses: COL2A1 and ACAN (Figure 1A, B) were signifi-
cantly higher at 2% compared with 20% oxygen, whereas
COL1A1 and COL10A1 (Figures 1C and 1D) were signifi-
cantly lower. Furthermore, the COL2A1: COL1A1 ratio
was consistently increased by hypoxia compared to nor-
moxia (9- to 87-fold in healthy pellets and 8- to 54-fold in
OA pellets; Additional file 2). Because of the higher varia-
bility of the increase in healthy cell pellets, this was not
significant at the a = 0.05 level (P = 0.097; P = 0.047 for
OA). There was no significant difference in the COL2A1:
COL1A1 ratio between healthy and OA cells at either oxy-
gen level. No statistically significant differences were
detected in expression levels between healthy and OA
chondrocytes at day 0 of pellet cultures, and COL10A1
was undetectable (data not shown); however, redifferentia-
tion led to differential changes in the two groups. COL2A1
and ACAN levels were similar between healthy and OA at
both oxygen levels, but COL1A1 and COL10A1 were
greater in OA chondrocyte pellets at 20% oxygen, a differ-
ence that was also significant for COL10A1 in 2% oxygen.
Oxygen-dependent patterns of collagen distribution
Regardless of the disease state, oxygen-dependent
changes in matrix production and organization detected
by immunohistochemical staining were similar (Figure 2).
Although pellets from both oxygen levels stained positive
for collagen II throughout the matrix, collagen I had dis-
tinct oxygen-dependent staining patterns. Pellets cultured
at 20% oxygen had the most intense collagen I staining
around the periphery of the pellets, where the cells also
had a distinctly elongated (fusiform) morphology. All pel-
lets cultured at 2% oxygen had qualitatively less collagen
I staining in the matrix than 20% oxygen pellets, and they
also lacked the flattened cells at their periphery. Addi-
tionally, the positive signal for collagen I in hypoxic pel-
lets appeared to be intracellular. Collagen X was barely
detectable in the matrices of both healthy and OA pellets,
but, as with collagen I, the strongest staining was at the
periphery of the pellets cultured at 20% oxygen.
Oxygen-dependent matrix production
DNA content was used to normalize biochemical mea-
sures of matrix production. Although there was no dif-
ference between healthy and OA chondrocytes in DNA
content at either oxygen level, OA pellets had signifi-
cantly lower DNA when cultured in 20% oxygen than in
2% oxygen (P = 0.030) (Figure 3A). In healthy chondro-
cytes, DNA content was not significantly different
between the two oxygen levels.
In both healthy and OA chondrocyte pellets, the mean
hydroxyproline/DNA was higher in 20% oxygen com-
pared with 2% oxygen (Figure 3B). In OA pellets, the
difference in this measure between the two oxygen
levels was significant. Despite the fact that, for each of
the five healthy donors’ chondrocytes, their 20% oxygen
pellets contained higher hydroxyproline/DNA than their
matched 2% oxygen cultures, this difference was not sig-
nificant (P = 0.075). Hydroxyproline content was not
significantly different between healthy and OA chondro-
cytes at either oxygen level.
Both healthy and OA chondrocytes had significantly
more sGAG/DNA in pellets at 2% compared with those
at 20% oxygen (Figure 3C). Although there was no sig-
nificant difference between healthy and OA chondro-
cytes at 2% oxygen, OA pellets had significantly less
sGAG/DNA than healthy counterparts at 20% oxygen
(Figure 3C). Culture medium sGAG content was quanti-
fied, and the degree of proteoglycan retention was
assessed, using sGAGs in pellets/total sGAGs produced
(Figure 3D). Not only was the percentage of sGAGs
retained within OA pellets significantly lower than that
of healthy pellets in 20% oxygen, but the percentage
retention of sGAGs was also found to be a significant
measure of the oxygen response of healthy and OA
chondrocytes. Although oxygen level did not affect
retention of sGAGs in healthy chondrocyte pellets, OA
pellets retained significantly less sGAGs at 20% oxygen.
Oxygen-dependent expression of catabolic and anabolic
enzymes
Expression of MMP1, MMP3 and MMP13 (Figures 4A
through 4C) were all significantly lower in 2% oxygen
than in 20% oxygen cultures for both healthy and OA
chondrocytes. MMP13 gene expression was both oxy-
gen- and disease state-dependent. At 20% oxygen, very
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high MMP13 gene expression levels seen in some OA
samples resulted in a mean 22-fold difference between
OA and healthy chondrocytes, but the wide variation
meant that statistical significance was not established
(P = 0.123). At 2% oxygen, however, MMP13 was signif-
icantly higher in OA than in healthy chondrocytes
(19-fold). Although these differences were observed in
redifferentiated pellets, there was no statistically signifi-
cant difference in MMP13 expression between healthy
and OA cells at day 0 of pellet culture (data not shown).
Like the other MMPs, MMP2 was significantly lower in
2% oxygen than in 20% oxygen for both healthy and OA
chondrocytes (Figure 4D). Furthermore, gelatin zymogra-
phy indicated that less of the active form of MMP2 was
generated at 2% oxygen (Figure 4E). Additionally, superna-
tants from healthy cells in 20% oxygen displayed unidenti-
fied gelatinolytic activity near 130 kDa. We could not
consistently detect MMP9 mRNA expression at either
oxygen level in either healthy or OA cells (data not
shown), and supernatants did not show gelatinolytic
activity in the molecular weight range where MMP9 is
typically detected (92 kDa).
Since MMP2 displayed oxygen-dependent generation of
its active form, we evaluated expression of the two essen-
tial members of the complex responsible for activation of
pro-MMP2 at the cell surface, tissue inhibitor of MMP 2
(TIMP2) and MMP14 (Figures 4F and 4G). Although
TIMP2 was not oxygen-dependent, like the other MMPs
evaluated, MMP14 was expressed at a significantly lower
level in 2% oxygen in both healthy and OA cells.
Neither aggrecanase 1 (ADAMTS4) nor aggrecanase 2
(ADAMTS5) (Figures 5A and 5B) had disease state-depen-
dent expression, regardless of the oxygen level. However,
expression of both genes showed some degree of oxygen-
dependent regulation. Both ADAMTS4 and ADAMTS5
were significantly higher in healthy chondrocytes at 20%
compared with 2% oxygen. Whereas their expression was
higher at 20% oxygen for both genes in four of the five OA
samples, this difference was not significant (P = 0.119 and
P = 0.127, respectively).
Figure 1 Oxygen-dependent expression of cartilage matrix genes in healthy and osteoarthritic chondrocytes. The relative gene expression levels
of COL2A1 (A), ACAN (B), COL1A1 (C) and COL10A1 (D) in pellet cultures following 2 wk of redifferentiation in either 20% oxygen (gray bars) or 2% oxygen
(white bars) were analyzed by real-time quantitative polymerase chain reaction. All values are the mean mRNA level normalized to 18S ribosomal RNA for
chondrocyte pellets from n = 5 donors. Error bars represent 1 SD. Statistical significance was determined by performing independent t-tests, Mann-
Whitney U test (between disease conditions) and paired t-test or Wilcoxon tests as appropriate (between oxygen levels). *P < 0.05.
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In addition to genes involved in modulating degrada-
tion, we evaluated expression of HAS2 (Figure 6A), a
candidate enzyme for improving proteoglycan retention
through hyaluronic acid production. HAS2 was signifi-
cantly higher in hypoxic conditions in OA chondrocytes;
in healthy cells, though it trended in the same direction,
the difference in expression between 2% and 20% oxy-
gen was nonsignificant (P = 0.150). As with ADAMTS4
and ADAMTS5 in the OA cells, HAS2 was lower in 20%
oxygen in all but one of the healthy donors’ chondrocyte
pellets. Additionally, bivariate analysis revealed a strong
and statistically significant correlation between the oxy-
gen-dependent difference in HAS2 and that of sGAG
retention in both OA cells (Pearson’s r = 0.909, P =
0.032) (Figure 6B) and healthy cells (Pearson’s r = 0.927,
P = 0.023) (Figure 6C). No significant correlation was
found for either ADAMTS4 or ADAMTS5.
HIF-1a and HIF-2a expression during chondrocyte
redifferentiation
Representative images of the patterns of HIF-1a and
HIF-2a expression for chondrocyte pellets are shown in
Figure 7. Expression patterns of both HIF-1a and HIF-2a
in healthy and OA chondrocytes were indistinguishable.
This was consistent with mRNA data for HIF1 and
EPAS1, which showed no significant differences between
healthy and OA cells at day 0 or at day 14, regardless of
oxygen level (data not shown). Little to no HIF-1a or
HIF-2a was detected throughout 20% oxygen cultures. In
contrast, both healthy and OA chondrocytes expressed
HIF-1a and HIF-2a at 2% oxygen, with the strongest sig-
nals occurring early (day 2). When day 2 protein from
hypoxic pellets was run on the same gel, we could not
determine a disease-dependent difference in band inten-
sity for either HIF-1a or HIF-2a (data not shown). In
addition to the bands detected at the predicted molecular
weights, there were other positive bands on the immuno-
blots. For HIF-1a, the additional bands were determined
to be specific, with a l-phosphatase digestion indicating
that they were due to phosphorylation (data not shown).
For HIF-2a, only the band of the predicted molecular
weight had oxygen-dependent expression; the identities
of the other bands could not be confirmed (Figure 7,
Additional file 3 and Additional file 4).
Figure 2 Oxygen-dependent patterns of collagen distribution in healthy and osteoarthritic chondrocytes. Representative images of
matrix staining patterns are shown. Paraffin sections were either double-stained with anti-collagen I and anti-collagen II antibodies or single-
stained with anti-collagen X as described in Materials and methods. 4′,6-diamidino-2-phenylindole was used as a counterstain for nuclei. Positive
immunolocalization of collagen appears in red (collagen II) or in green (collagen I, collagen X), and nuclei are shown in blue. Negative controls
with isotype-matched antibodies (images not shown) were used for background correction. Composite images of matrix staining and nuclei
were digitally processed using ImageJ software (National Institutes of Health, Bethesda, MD, USA). Scale bars = 100 μm.
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Discussion
In this study, we evaluated the oxygen-dependent response
of healthy and OA chondrocytes during redifferentiation.
We hypothesized that OA chondrocytes might have a dif-
ferent response to changes in oxygen levels compared
with healthy chondrocytes, such that reduced oxygen
would promote hypertrophic and degenerative changes in
OA chondrocytes concomitant with different HIF expres-
sion patterns. However, our data indicate that redifferen-
tiation was promoted, hypertrophic and OA-associated
degradative genes were suppressed and HIF expression
patterns were indistinguishable in both healthy and OA
chondrocytes in hypoxic conditions.
Healthy and OA chondrocytes both responded with
higher COL2A1 and ACAN and lower COL1A1 expres-
sion in hypoxic conditions. Hypoxic culture has pre-
viously been found to increase COL2A1 and ACAN in
nondiseased chondrocytes [8,9] and independently in
chondrocytes from joint arthroplasties [24]. In a direct
comparison, we found no differences in expression of
these genes between healthy and diseased cells, regardless
of oxygen tension. Additionally, though COL1A1 was
higher in OA chondrocytes than in healthy chondrocytes
at 20% oxygen, lower COL1A1 and less collagen I matrix
staining was associated with all cells redifferentiated in
hypoxia. Collagen prolyl hydroxylases require molecular
oxygen, and the decreases in hydroxyproline content at
2% oxygen indicate that this level of hypoxia impairs the
activity of these enzymes. It is possible that, when oxygen
levels are low enough that these enzymes are impaired in
chondrocytes, prolyl hydroxylation and thus secretion of
collagen type II is preferentially maintained over other
collagens. Consistent with this theory, the COL2A1:
COL1A1 ratio was consistently elevated by hypoxia in
our studies.
We also found that hypoxia increased proteoglycan
accumulation by both healthy and OA cells. Excess oxy-
gen may be more detrimental to cells from OA joints,
Figure 3 Oxygen-dependent matrix production in healthy and osteoarthritic chondrocytes. The DNA content per pellet (A),
hydroxyproline/DNA (B), sulfated glycosaminoglycans (sGAGs)/DNA (C) and percentage of total sGAGs retained in the pellet matrix (D) were
quantified for papain-digested pellets following 2 wk of redifferentiation in either 20% oxygen (gray bars) or 2% oxygen (white bars). All values
are the means ± 1 SD for chondrocyte pellets from n = 5 donors. Statistical significance was determined by performing independent t-tests or
Mann-Whitney U test (between disease conditions) and paired t-test or Wilcoxon tests as appropriate (between oxygen levels). *P < 0.05.
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however, because OA cell pellets had significantly less
sGAG/DNA than those of healthy cells maintained at high
oxygen. Whether this is due to a greater oxygen sensitivity
that results in impaired synthesis, more degradation,
disturbed matrix assembly or some combination of these
processes remains to be determined. The percentage of
sGAGs retained within the matrix was also significantly
reduced in OA chondrocytes at 20% oxygen. This may be
Figure 4 Oxygen-dependent expression of matrix metalloproteinases in healthy and osteoarthritic chondrocytes. (A) through (D) The
relative gene expression levels of MMP1, MMP3, MMP13 and MMP2 in pellet cultures following 2 wk of redifferentiation in either 20% oxygen
(gray bars) or 2% oxygen (white bars) were analyzed by real-time quantitative polymerase chain reaction. (E) Gelatin zymography of supernatants
pooled from days 9 to 14 of pellet cultures indicates levels of secreted pro-MMP2 and active MMP2 in healthy and osteoarthritic (OA) cells at
20% and 2% oxygen. (F) and (G) The relative gene expression levels of TIMP2 and MMP14 in pellet cultures following 2 wk of redifferentiation in
either 20% oxygen (gray bars) or 2% oxygen (white bars) were analyzed by real-time quantitative polymerase chain reaction. All expression
values are the mean mRNA levels normalized to 18S ribosomal RNA for chondrocyte pellets from n = 5 donors. Error bars represent 1 SD.
Statistical significance was determined by performing independent t-tests (between disease conditions) and paired t-tests (between oxygen
levels). *P < 0.05.
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indicative of poorer proteoglycan incorporation into the
matrix or of increased degradation. With regard to the for-
mer possibility, we assessed expression of HAS2, the pre-
dominant form of the HAS enzyme in chondrocytes
[25,26]. Previously, studies using RNA interference against
HAS2 showed that this did not affect ACAN expression or
proteoglycan synthesis, but that it did decrease the amount
of proteoglycans retained within the matrix [25]. HAS2
expression and hyaluronic acid synthesis have also been
shown to be oxygen-dependent in bovine chondrocytes
[27]. We found that 20% oxygen resulted in lower mean
HAS2 expression in both healthy and OA chondrocytes.
Furthermore, there was a strong correlation between the
oxygen-dependent difference in HAS2 and that of sGAG
retention in both healthy and OA cells. Reduced hyaluro-
nic acid synthesis could allow for more passive loss of
Figure 5 Oxygen-dependent expression of aggrecanases in healthy and osteoarthritic chondrocytes. The relative gene expression levels
of ADAMTS4 (A) and ADAMTS5 (B) in pellet cultures following 2 wk of redifferentiation in either 20% oxygen (gray bars) or 2% oxygen (white
bars) were analyzed by real-time quantitative polymerase chain reaction. All values are the mean mRNA levels normalized to 18S ribosomal RNA
for chondrocyte pellets from n = 5 donors. Error bars represent 1 SD. Statistical significance was determined by performing independent t-tests
(between disease conditions) and paired t-tests (between oxygen levels). *P < 0.05.
Figure 6 Oxygen-dependent expression of hyaluronic acid synthase 2 (HAS2) in healthy and osteoarthritic chondrocytes and
correlation with sulfated glycosaminoglycan retention. (A) The relative gene expression levels of HAS2 in pellet cultures following 2 wk of
redifferentiation in either 20% oxygen (gray bars) or 2% oxygen (white bars) was analyzed by real-time quantitative polymerase chain reaction.
All values are the mean mRNA levels normalized to 18S ribosomal RNA for chondrocyte pellets from n = 5 donors. Error bars represent 1 SD.
Statistical significance was determined by performing independent t-tests (between disease conditions) and paired t-tests (between oxygen
levels). *P < 0.05. (B) and (C) The oxygen-dependent change in sulfated glycosaminoglycan (sGAG) matrix retention (percentage retained at 2%
oxygen/percentage retained at 20% oxygen) was plotted against the oxygen-dependent changes in HAS2 expression (HAS2 at 2% oxygen/HAS2
at 20% oxygen) for healthy (B) and osteoarthritic (OA) pellets (C). Linear regression fit and coefficient of determination (R2) are shown. Bivariate
analysis revealed a strong and statistically significant correlation between the oxygen-dependent difference in HAS2 and that of sGAG retention
in both OA cells (P = 0.032) and healthy cells (P = 0.023).
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proteoglycans; however, hyaluronic acid has also been
reported to modulate expression and/or activity of
ADAMTS4 [28] and MMP13 [29] in chondrocytes. Deter-
mining specific mechanisms by which HAS2 modulation
by oxygen affects chondrocytes and their matrix requires
further investigation.
The potent anabolic effects of hypoxia on chondrocytes
are well-documented, but less is known about its regula-
tion of catabolism. In the two studies implicating HIF-2a
in hypertrophy and OA, MMP3, MMP9/Mmp9 and
MMP13 were reported to be upregulated by HIF-2a
[12,13]. One of the studies also reported MMP1 and
Adamts4, but not Adamts5, to be promoted by HIF-2a
[13], but the other found no association for either
Adamts4 or Adamts5. In contrast, hypoxia reportedly
decreases MMP1 and MMP13 expression and collagenoly-
tic activity in healthy human chondrocytes and decreases
ADAMTS5 and aggrecanase activity in healthy human car-
tilage explants [10,11]. We found that MMP1 and MMP13
were lower in hypoxia not only in healthy chondrocytes
but also in OA chondrocytes. Additionally, MMP2 and
MMP3 were lower in both healthy and OA chondrocytes
in hypoxic culture, and less of the active form of MMP-2
was generated, concomitant with lower expression of
MMP14. As reported by Ströbel et al., we detected no oxy-
gen-dependent changes in MMP9 expression, because this
gene was at the limit for detection in both healthy and OA
cells [11]. ADAMTS4 and ADAMTS5 were also lower in
both healthy and OA chondrocytes in hypoxia, but the
differences were significant only in healthy cells. Although
hypoxia was associated with transcriptional downregula-
tion of these enzymes, we did not address the potential for
oxygen-dependent activity. Like MMPs, the ADAMTS
proteases are synthesized as inactive zymogens and asses-
sing whether and to what extent their activation is oxy-
gen-dependent is an essential next step in understanding
the role of oxygen in cartilage degeneration. Recent find-
ings by Thoms et al. indicate that hypoxic culture does
indeed suppress loss of aggrecanase-generated aggrecan
fragments from healthy cartilage explants and that TIMP3
may play a role in the oxygen-dependent inhibition [10].
We found that COL10A1 was dramatically lower at 2%
oxygen compared with 20% oxygen in both healthy and
OA chondrocytes. This finding contrasts with that of
Schrobback et al., who reported that COL10A1 was not
oxygen-dependent in chondrocytes from patients under-
going arthroplasty [30]. However, they used 5% oxygen,
and, though it was reported as nonsignificant, COL10A1
was on average lower at 5% oxygen than at 20% oxygen.
Because our data suggest that OA chondrocytes may be
particularly sensitive to oxygen, the different oxygen
levels could explain the discrepancies. Compared to stan-
dard culture conditions, human neuroblastoma cells
grown at 5% oxygen were reported to have elevated levels
of HIF-2a only, whereas those grown at 1% oxygen had
increased levels of both HIF-1a and HIF-2a [31].
Although the relative contributions of the HIFs to col-
lagen type expression remain unknown, we observed
Figure 7 Hypoxia-inducible factors 1a and 2a protein expression during redifferentiation of healthy and osteoarthritic chondrocytes.
Representative images of banding patterns are shown. Normalization of nuclear protein loading was achieved by first running equal volumes of
each sample and probing for histone H3. For hypoxia-inducible factor (HIF) blots, the volume loaded was adjusted to give equivalent nuclear
loading based on each histone H3 band’s signal relative to the signal from the lowest-intensity band. The location of the only oxygen-
dependent band on HIF-2a blots is in the boxed area, and the blot is cropped to show only the bands in the molecular weight range where
the HIF-2a product is predicted (115 kDa). Unmodified HIF-2a blots for healthy and OA chondrocytes are shown in Additional files 3 and 4,
respectively. The consistency of the nonspecific band near 35 kDa (lowest band) was used as a loading control after histone H3 normalization.
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increased levels of both HIF-1a and HIF-2a at 2% oxy-
gen. If expression patterns of the HIFs vary in chondro-
cytes at higher oxygen levels, this could alter collagen
expression profiles.
Our finding that hypoxia decreases COL10A1 also
seems to be at odds with results reported by Saito et al.
indicating that HIF-2a was a potent transactivator of
COL10A1, at least when paired with the b-subunit of
ARNTL [12]. This discrepancy is not inexplicable,
because it is known that HIFs are posttranslationally
modified in a number of ways that may be dependent on
culture conditions, including oxygen tension, and we per-
formed our studies in hypoxic conditions, whereas Saito
et al. did theirs at 20% oxygen. For example, both HIF-
1a [32,33] and HIF-2a [34] have been reported to be
phosphorylated in hypoxia. Although we cannot confirm
the presence of HIF-2a modifications, phosphorylation
of HIF-1a appears to be relevant in chondrocytes. The
overexpression studies conducted in standard oxygen
conditions could alter such regulatory mechanisms of
HIF signaling and contribute to reported differences.
With the reports of HIF-2a’s involvement in promoting
hypertrophic genes came suggestions that targeting HIF-
2a could be an effective treatment for OA [17]. As was
also noted, targeting the relevant dimerization partners
involved in promoting these genes may be a more suita-
ble strategy. Our results support this alternate view,
because the absence of HIF expression in human chon-
drocytes is associated with increased markers of hyper-
trophy and degeneration and the banding patterns of the
HIF a-subunits were identical, regardless of the cells’
origin.
Although there were no obvious differences in the
response of HIF-1a and HIF-2a expression between
healthy and OA cells, because more of the measured out-
comes were affected by high oxygen in OA chondrocytes,
we cannot rule out that there are differences in oxygen-
dependent signaling in OA chondrocytes compared with
healthy chondrocytes. With higher oxygen exposure, OA
chondrocytes have significantly higher COL1A1 and
COL10A1 mRNA expression compared with healthy
chondrocytes and exhibit loss of proteoglycans from the
matrix in addition to having lower cell numbers at the
end of the culture period compared with their hypoxic
counterparts. Although there were differences between
redifferentiated healthy and OA chondrocytes that were
evident or more pronounced only under higher oxygen
tension, only the expression levels of COL10A1 and
MMP13 were significantly different between healthy and
OA cells under hypoxic conditions. There may be HIF
signaling-related mechanisms that are responsible for the
disease state-dependent differences we see in certain
parameters of redifferentiation. The a-subunits are
generally assumed to be the rate-limiting factors because
they are specific to hypoxic targets, unlike the promiscu-
ous b-subunits. However, we cannot rule out that the
presence and relative ratios of the b-subunits and control
of dimerization could affect HIF activity in ways that
would not be detected by Western blot analysis for HIF
a-subunits. In addition, the asparginyl hydroxylase factor
inhibiting HIF, which blocks coactivator recruitment,
may be differentially regulated. Furthermore, epigenetic
phenomena have been shown to be involved in the regu-
lation of HIF target gene expression in chondrocytes.
Hashimoto et al. demonstrated that methylation of CpG
sites in the hypoxia-responsive element in the proximal
promoter region of MMP13 inhibited HIF-2a-dependent
transactivation [35]. This is an intriguing line of inquiry
and may provide a valuable key to understanding the pat-
terns of gene expression we describe and possibly even a
mechanism for the donor-to-donor variation observed
with primary cells.
Conclusions
Hypoxic culture lessens the differences between OA and
healthy chondrocytes, and the effect of elevated oxygen
leads to changes in both healthy and OA chondrocytes
that are generally associated with degenerative cartilage.
This implies that a loss of HIF signaling could be
involved in promoting changes associated with cartilage
degradation. However, these studies were done in the
absence of external stress signals, such as inflammatory
factors, which could modulate HIF signaling and alter
the downstream effects. That the detrimental effects of
high oxygen are greater in the OA chondrocytes indi-
cates that diseased cells may be less equipped to miti-
gate the stress of impaired HIF signaling and that this
difference is maintained through in vitro expansion.
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Additional file 1: Macroscopic and toluidine blue-stained sections of
healthy and osteoarthritic cartilage specimens. Representative
cartilage specimen images of healthy (A) and (C) and OA (B) and (D)
are shown.
Additional file 2: Ratio of COL2A1 to COL1A1 expression in healthy
and osteoarthritic chondrocytes. The ratios of the relative gene
expression levels of COL2A1 and COL1A1 in pellet cultures following 2 wk
of redifferentiation in either 20% oxygen (gray bars) or 2% oxygen (white
bars) were calculated. All values are the mean ratios from n = 5 donors.
Error bars represent 1 SD. Statistical significance was determined by
performing independent t-tests (between disease conditions) and paired
t-tests (between oxygen levels). *P < 0.05.
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chondrocyte HIF-2a blot shown in Figure 7.
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